Pharmacologic or genetic inhibition of PKM2 or EIF2AK2 hampers NLRP3 inflammasome activation and protects mice from lethal endotoxemia and polymicrobial sepsis [78]. This evidence concerns the gene EIF2AK2 and serum lipopolysaccharide activity.